Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Developed proprietary soybean seeds with enhanced protein content, oil quality, digestibility, and low anti-nutrient traits using AI-driven predictive breeding. Commercialized Ultra High Protein soybeans for food/feed/fuel markets. Company filed for bankruptcy in March 2025; assets acquired by Confluence Genetics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Benson Hill.